Sintx Technologies, Inc. (SINT)
$0.423
+0.03 (+6.31%)
Rating:
Recommendation:
-
| Symbol | SINT |
|---|---|
| Price | $0.423 |
| Beta | 1.655 |
| Volume Avg. | 0.17M |
| Market Cap | 1.802M |
| Shares () | - |
| 52 Week Range | 0.335-15.1 |
| 1y Target Est | - |
| DCF Unlevered | SINT DCF -> | |
|---|---|---|
| DCF Levered | SINT LDCF -> | |
| ROE | -96.07% | Strong Sell |
| ROA | -71.45% | Strong Sell |
| Operating Margin | - | |
| Debt / Equity | 17.91% | Neutral |
| P/E | -0.01 | Neutral |
| P/B | 0.17 | Neutral |
Latest SINT news
About
Download (Excel)Dr. B. Sonny Bal J.D., M.B.A., M.D., Ph.D.
Healthcare
Medical Devices
NASDAQ Capital Market
Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications primarily in the United States. The company provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.